Merrion Pharmaceuticals begin IEX trading
Shares in Merrion Pharmaceuticals began trading today on IEX, the Irish Stock Exchange’s specialist market for small and medium-sized companies.
Merrion is raising €8m (gross) in new equity and will have a starting market capitalisation of €67.16 m based on the issue price of €4.05 per share. Merrion is the first company to seek an IEX only listing and brings the number of companies on IEX to 30.





